Robert A. Winn Diversity in Clinical Trials Award Program

Diversity in Clinical Trials Career Development Program
  • Home
  • About Us
  • Winn CDA
    • The Need
    • Our Vision
    • Goals
    • Program Model
    • Program Requirements
    • Key Program Elements
    • Application Information
  • Winn CIPP
    • The Need
    • Our Mission and Vision
    • Goals
    • Program Model
    • Key Program Elements
    • Application Information
  • Informational Webinars
  • Nat'l Advisory Committee
  • In The News
  • Contact Us
  • FAQs
  • More
    • Home
    • About Us
    • Winn CDA
      • The Need
      • Our Vision
      • Goals
      • Program Model
      • Program Requirements
      • Key Program Elements
      • Application Information
    • Winn CIPP
      • The Need
      • Our Mission and Vision
      • Goals
      • Program Model
      • Key Program Elements
      • Application Information
    • Informational Webinars
    • Nat'l Advisory Committee
    • In The News
    • Contact Us
    • FAQs
Diversity in Clinical Trials Career Development Program
  • Home
  • About Us
  • Winn CDA
  • Winn CIPP
  • Informational Webinars
  • Nat'l Advisory Committee
  • In The News
  • Contact Us
  • FAQs

Winn cda Application information

Candidate Eligibility Criteria

Candidate Profile

Eligible candidates will reflect the National Science Foundation (NSF) definition of underrepresented populations in the US Biomedical, Clinical, Behavioral and Social Sciences Research Enterprise:


  • African American or Black
  • Hispanic or Latino
  • American Indian or Alaska Native
  • Native Hawaiian or Other Pacific Islander


OR have a demonstrated commitment to increasing diverse patient participation in clinical trials.


Citizenship or immigration status 

Eligible candidates will be US Citizens or Lawful Permanent Residents (LPRs) as defined by the US Department of Homeland Security. [NOTE: H-1B and O-1 Visa holders are eligible; the Visa must be valid during the full 2-yr period]   


Professional degree 

Eligible candidates will hold the degree of MD, MD/PhD, DO or DO/PhD 


Career Phase

Eligible candidates will be Early-Stage Investigators (ESIs), defined by NIH as new investigators who have completed their terminal research degrees or medical residencies - whichever date is later - within the past 10 years and have not yet competed successfully for substantial NIH research grants. (Applicants with an RO1 or RO1 equivalent are ineligible.)
 

Targeted Key Dates

Letter of Intent (LOI) Submission Opened: 

Oct 18, 2021

 

LOI Submission Closed: 

Mar 15, 2022 


Application Opened (By Invitation Only): 

Jan 31, 2022

 

Application Closes:

May 13, 2022


Selection Process: 

May 16 - Aug 1, 2022

 

Award Notifications:

Aug 2, 2022

 

Cohort 2 Begins:

Oct 2022


Note: Dates are subject to change.

Letter of Intent

Letter of Intent

Letter of Intent

What are the LOI components? Click below for more information.

Learn more

application

Letter of Intent

Letter of Intent

Interested in what the full application entails? Click below for a peek.

Learn more

Learn More About the Program

Learn More About the Program

Learn More About the Program

Visit our Informational Webinar page to view a recorded webinar!

Learn more

Submit a Letter of Intent

Learn More About the Program

Learn More About the Program

Apply now

questions?

Learn More About the Program

questions?

Email the Winn CDA Team with any questions!

contact us

Copyright © 2022

 Robert A. Winn Diversity in Clinical Trials Award Program. All Rights Reserved.

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

DeclineAccept